UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025838
Receipt number R000029710
Scientific Title Assessment of Pancreatic exocrine function of hospitalized patients with heart failure
Date of disclosure of the study information 2017/01/25
Last modified on 2023/09/25 22:52:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of Pancreatic exocrine function of hospitalized patients with heart failure

Acronym

Assessment of Pancreatic exocrine function of hospitalized patients with heart failure

Scientific Title

Assessment of Pancreatic exocrine function of hospitalized patients with heart failure

Scientific Title:Acronym

Assessment of Pancreatic exocrine function of hospitalized patients with heart failure

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Hepato-biliary-pancreatic medicine Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the pancreatic exocrine function in patients with heart failure

Basic objectives2

Others

Basic objectives -Others

Exploratory

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pancreatic exocrine function measured using PFD (pancreatic function diagnostic) test

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Pancreatic functional diagnosis test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

hospitalized patients with heart failure
hospitalized patients without heart failure

Key exclusion criteria

Patients with end-stage renal disease (eGFR<30 ml/min) including hemodialysis
Patients with acute pancreatitis
Patients with acute hepatitis
Patients with other diseases which may affect pancreatic exocrine function
Patients with the medicine which may affect pancreatic exocrine function
Pregnancy and patients who is possible to be pregnant
Patients who did not consent
Patients who are considered as inappropriate based on the principle investigators judgement

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takatoshi
Middle name
Last name Kasai

Organization

Juntendo University Hospital

Division name

Department of Cardiovasacular Medicine

Zip code

113-8431

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.

TEL

03-3813-3111

Email

tkasai@juntendo.ac.jp


Public contact

Name of contact person

1st name Takatoshi
Middle name
Last name Kasai

Organization

Juntendo University Hospital

Division name

Department of Cardiovasacular Medicine

Zip code

113-8431

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan.

TEL

03-3813-3111

Homepage URL


Email

tkasai@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

we have no funding source

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo Hospital Ethics Committee

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.

Tel

03-5802-1584

Email

kenkyu5858@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 27 Day

Date of IRB

2017 Year 01 Month 06 Day

Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 25 Day

Last modified on

2023 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029710


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name